Pay in 4 interest-free payments of $6.06 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health
Remarkably, BPC-157 stands out as the sole peptide amenable to oral administration, retaining its efficacy amidst the hostile acidity of the gut
Triple receptor profile GLP-1R, GIPR, and GCGR simultaneous engagement in research models Referenced in peer-reviewed literature on triple incretin receptor pharmacology Useful for comparative studies alongside single and dual agonist reference compounds Lyophilized format ensures stability and reproducibility across experimental runs Batch and lot identifiers on all labeling for full laboratory documentation compliance Research Background GLP3-R (Retatrutide) has been referenced in scientific literature as a GLP-1/GIP/glucagon receptor triple agonist
Maintaining healthy habits, such as a balanced diet and regular exercise, is key to keeping weight off after stopping GLP-1 treatment
US$ 28.85
US$ 21.15
US$ 23.26
US$ 21.03
US$ 20.52
US$ 24.80
US$ 27.35
US$ 22.05
